Biostatistics is an essential component of all of the three major areas of cancer research - basic, clinical and population science. The Biostatistics Shared Resource (BSR) provides the necessary infrastructure to facilitate the collaboration between the investigator and a biostatistician from the planning stage of a project through its execution, analysis and interpretation and finally the dissemination stages. The objectives of this resource are: ? To collaborate with HICCC investigators in the design, conduct, analysis, interpretation and reporting of their clinical, laboratory and population science studies. ? To provide short-term statistical consulting to HICCC members. ? To collaborate with the HICCC investigators in their research initiatives and grant proposals. ? To advise the Protocol Review and Monitoring Committee by providing statistical review of the design of studies and their conduct. ? To interact with the Biomedical Informatics Shared Resource in the development and maintenance of the clinical research database. The Biostatistics Shared Resource has been part of the HICCC since its inception and it provides support for all of its members. This shared resource underwent significant personnel changes during the last grant period. The HICCC has appointed Dr. Venkatraman Seshan as the new Director of the BSR and has committed substantial institutional support to its growth in response to the demand for its services. Dr. Seshan joined Columbia University and HICCC in July 2007 and brings nearly 15 years of biostatistics experience specially focused on cancer research. Currently there are nine doctoral level biostatisticians with a wide range of methodological expertise and collaborative experience in the BSR representing an involvement of 3.5 FTEs in cancer research. In light of the plans for new recruitment and the institutional support for the growth, this resource is well positioned to cultivate and promote the collaborations between HICCC investigators and the biostatisticians that result in the highest quality cancer research. During the last period of the CCSG, the BSR has collaborated with 41 investigators, 56% of whom have been Cancer Center members with peer-reviewed funding. The total operating budget of the facility is $653,604 of which we are requesting $114,616 from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA013696-39S3
Application #
8637170
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-07-04
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
39
Fiscal Year
2013
Total Cost
$136,392
Indirect Cost
$51,147
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Sones, Jennifer L; Merriam, Audrey A; Seffens, Angelina et al. (2018) Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia. FASEB J 32:2574-2586
Park, Karen Sophia; Xu, Christine L; Cui, Xuan et al. (2018) Reprogramming the metabolome rescues retinal degeneration. Cell Mol Life Sci 75:1559-1566
Mumau, Melanie D; Vanderbeck, Ashley N; Lynch, Elizabeth D et al. (2018) Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1. J Immunol 200:1078-1087
Savage, Thomas M; Shonts, Brittany A; Obradovic, Aleksandar et al. (2018) Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. JCI Insight 3:
Caviglia, Jorge Matias; Yan, Jun; Jang, Myoung-Kuk et al. (2018) MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology 67:2414-2429
Jauregui, Ruben; Park, Karen Sophia; Tsang, Stephen H (2018) Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa. Ophthalmic Genet 39:544-549
Wu, Wen-Hsuan; Tsai, Yi-Ting; Justus, Sally et al. (2018) CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology. Methods Mol Biol 1715:191-205
Yen, Bonnie; Fortson, Katherine T; Rothman, Nyanza J et al. (2018) Clonal Bifurcation of Foxp3 Expression Visualized in Thymocytes and T Cells. Immunohorizons 2:119-128
Ishida, Chiaki T; Zhang, Yiru; Bianchetti, Elena et al. (2018) Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma. Clin Cancer Res 24:5392-5406
Jin, Chun-Hui; Li, Yang; Xia, Jinxing et al. (2018) CXCR4 blockade improves leukemia eradication by allogeneic lymphocyte infusion. Am J Hematol 93:786-793

Showing the most recent 10 out of 331 publications